Where does Qlaris Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Qlaris Bio's 4 recorded funding rounds.

Premier Alternatives

Qlaris Bio

Dedham, MA · Founded 2019 · Privately Held (backing)

Developer of novel therapies designed to treat serious and debilitating ophthalmic diseases. Qlaris Bio is based in Dedham, MA and was founded in 2019. Its last reported valuation was $68 million in Apr 2024. It has raised $55 million across 4 recorded rounds; the latest was a $3.9 million seed round in Jun 2026.

Last reported valuation

$68.0M

Oct 2026

Priced at

—

Total raised

$55.0M

Last round

Seed Round

Jun 2026

Cap table — not yet on record

Qlaris Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Qlaris Bio with a free account

·Watch Qlaris Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Qlaris Bio

Where does Qlaris Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Qlaris Bio's 4 recorded funding rounds.